BioCentury
ARTICLE | Financial News

Arvinas raises $120M in IPO

September 28, 2018 6:19 PM UTC

Arvinas Inc. (NASDAQ:ARVN) raised $120 million late Sept. 26 through the sale of 7.5 million shares at $16 in its bumped-up IPO. The price, at the top of its proposed $14-$16 range, values the company at $514.5 million. Arvinas proposed earlier this month to sell 6.7 million shares. Underwriters are Goldman Sachs, Citigroup and Piper Jaffray.

Arvinas gained $0.05 to $16 on Sept. 27...

BCIQ Company Profiles

Arvinas Inc.

BCIQ Target Profiles

Androgen receptor